VYTRUS BIOTECH EO -01 Financial Flexibility Index
VYTRUS BIOTECH EO -01 financial flexibility index. VYTRUS BIOTECH EO -01 (V5P) has a Financial Flexibility Index of 1.51x as of December 2025. Free cash flow of €6.58 Million (operating CF €3.90 Million minus capex €2.68 Million) represents 2% of total liabilities (€4.35 Million). See cash generation quality of VYTRUS BIOTECH EO -01 to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of VYTRUS BIOTECH EO -01 (2021–2025)
Financial flexibility index of VYTRUS BIOTECH EO -01 from 2021 to 2025. Historical Financial Flexibility Index trend for VYTRUS BIOTECH EO -01 across 5 annual periods. Check VYTRUS BIOTECH EO -01 cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
VYTRUS BIOTECH EO -01 Financial Flexibility Index by Year (2021–2025)
VYTRUS BIOTECH EO -01 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for VYTRUS BIOTECH EO -01. For the full cash flow conversion analysis, see VYTRUS BIOTECH EO -01 cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | €6.58 Million | €3.90 Million | €4.35 Million | ▲ +90.3% |
| 2024 | 0.79x | €3.05 Million | €1.84 Million | €3.84 Million | ▲ +54.2% |
| 2023 | 0.51x | €2.07 Million | €904.39K | €4.02 Million | ▼ -27.9% |
| 2022 | 0.71x | €2.32 Million | €1.03 Million | €3.25 Million | ▲ +190.9% |
| 2021 | 0.25x | €719.74K | €447.92K | €2.93 Million | — |